Viewing Study NCT04513834



Ignite Creation Date: 2024-05-06 @ 3:05 PM
Last Modification Date: 2024-10-26 @ 1:42 PM
Study NCT ID: NCT04513834
Status: COMPLETED
Last Update Posted: 2024-04-22
First Post: 2020-08-12

Brief Title: Efficacy of a Multi-faceted Intervention Combining an Educational Outreach Visit to General Practitioners and Patient Education Material to Deprescribe Proton Pump Inhibitors PPI a Population-based Pragmatic Cluster-randomized Controlled Trial
Sponsor: Nantes University Hospital
Organization: Nantes University Hospital

Study Overview

Official Title: Efficacy of a Multi-faceted Intervention Combining an Educational Outreach Visit to General Practitioners and Patient Education Material to Deprescribe Proton Pump Inhibitors PPI a Population-based Pragmatic Cluster-randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DeprescrIPPDAM
Brief Summary: Deprescribing is defined as the process of withdrawal of an inappropriate medication supervised by a health care professional with the goal of managing the polypharmacy and improving outcomes Inappropriate use of proton pump inhibitors PPI is associated with severe adverse drug reactions and a major economic impact Deprescribing should be considered when inappropriate prescription of PPI is identified

DeprescrIPP DAM is a pragmatic trial population-based designed in clusters It wil assess the efficacy of a multi-faceted intervention an educational outreach visit to general practitioners associated with the sending of patient education material to their patients to deprescribe PPI
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None